Jatenzo, an oral formulation of the active pharmaceutical ingredient testosterone undecanoate, received FDA approval on April 2, 2019 [1]. This medication is indicated for the treatment of adult men with hypogonadism, or low testosterone [1][2].
What is Jatenzo used for?
Jatenzo is prescribed to raise testosterone levels in adult males diagnosed with hypogonadism, a condition characterized by insufficient testosterone production [1][2].
How does Jatenzo work?
Testosterone undecanoate, the active component in Jatenzo, is an ester of testosterone. It is designed to be absorbed into the bloodstream, where it is hydrolyzed to testosterone, thereby restoring normal physiological levels [1].
When does Jatenzo's patent expire?
Information regarding Jatenzo's specific patent expiry dates is available through resources like DrugPatentWatch.com [3]. The duration of patent protection can influence the timeline for generic competition.
Who manufactures Jatenzo?
Jatenzo is developed and manufactured by Clarus Therapeutics Holdings, Inc [1].
What are the potential side effects of Jatenzo?
Common side effects reported with Jatenzo include elevated blood pressure, headache, and pain in the nasopharynx [1]. Patients should discuss any potential risks with their healthcare provider.
Are there alternatives to Jatenzo for low testosterone?
Besides oral formulations like Jatenzo, testosterone replacement therapy is also available in various forms, including injectable solutions, transdermal patches, and topical gels [4]. These different delivery methods offer varying dosing schedules and absorption profiles.